Literature DB >> 3890932

Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease.

C Perreault, M Pelletier, R Belanger, J Boileau, Y Bonny, M David, M Gyger, D Landry, S Montplaisir.   

Abstract

Langerhans cells (LC) are bone marrow-derived dendritic antigen-presenting cells found in the epidermis. In an effort to determine the origin (host versus donor) of LC at different intervals following bone marrow transplantation, we performed skin biopsies in 16 recipients of sex-mismatched marrow. LC were identified using monoclonal antibody OKT6 in an indirect immunoperoxidase assay and their donor or host origin determined according to the presence or absence of Y body. The presence of Y-positive (donor) LC could be demonstrated in all (6/6) skin biopsies of female recipients of male marrow tested between days 39 and 730 post-transplant. Persistence of host LC in male recipients of female marrow was documented in all (6/6) recipients studied on day 39 and in two out of seven patients tested on day 120 post-transplant. From day 365 onward, no residual host LC could be detected, suggesting that by this time all epidermal LC are donor-derived. Our study demonstrates that host LC usually persist for 39 and up to 120 d following bone marrow transplantation. The relevance of this observation to the possible role of LC and other host dendritic antigen-presenting cells in the graft-versus-host reaction is discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3890932     DOI: 10.1111/j.1365-2141.1985.tb07411.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

Review 1.  Graft versus leukemia in bone marrow transplantation.

Authors:  M Boranić
Journal:  Blut       Date:  1988-08

2.  Effect of UVB radiation on the skin after allogeneic bone-marrow transplantation in man.

Authors:  W Torinuki; G Mauduit; D Guyotat; E Archimbaud; D Fiere; J Thivolet
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.

Authors:  Marco Mielcarek; Anna Yasmine Kirkorian; Robert C Hackman; Jeremy Price; Barry E Storer; Brent L Wood; Marylene Leboeuf; Milena Bogunovic; Rainer Storb; Yoshihiro Inamoto; Mary E Flowers; Paul J Martin; Matthew Collin; Miriam Merad
Journal:  Transplantation       Date:  2014-09-15       Impact factor: 4.939

4.  Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease.

Authors:  Marina Kreutz; Sigrid Karrer; Petra Hoffmann; Eva Gottfried; Rolf-Markus Szeimies; Joachim Hahn; Matthias Edinger; Michael Landthaler; Reinhard Andreesen; Miriam Merad; Ernst Holler
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

5.  Langerhans cells are not required for graft-versus-host disease.

Authors:  Hongmei Li; Daniel H Kaplan; Catherine Matte-Martone; Hung Sheng Tan; Srividhya Venkatesan; Kody Johnson; Anthony J Demetris; Jennifer McNiff; Mark J Shlomchik; Warren D Shlomchik
Journal:  Blood       Date:  2010-10-13       Impact factor: 22.113

6.  Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation.

Authors:  H Hessel; J Mittermüller; H Zitzelsberger; H U Weier; M Bauchinger
Journal:  Histochem Cell Biol       Date:  1996-11       Impact factor: 4.304

7.  STR typing of skin swabs from individuals after an allogeneic hematopoietic stem cell transplantation.

Authors:  Roland Reibke; Katja Anslinger; Dagmar von Máriássy; Mareike Verbeek; Britta Gätjens; Roberta Schiller
Journal:  Int J Legal Med       Date:  2022-06-03       Impact factor: 2.686

8.  Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.

Authors:  Miriam Merad; Petra Hoffmann; Erik Ranheim; Sarah Slaymaker; Markus G Manz; Sergio A Lira; Israel Charo; Donald N Cook; Irving L Weissman; Samuel Strober; Edgar G Engleman
Journal:  Nat Med       Date:  2004-04-18       Impact factor: 53.440

9.  CD1c+ blood dendritic cells have Langerhans cell potential.

Authors:  Paul Milne; Venetia Bigley; Merry Gunawan; Muzlifah Haniffa; Matthew Collin
Journal:  Blood       Date:  2014-10-28       Impact factor: 25.476

10.  The fate of human Langerhans cells in hematopoietic stem cell transplantation.

Authors:  Matthew P Collin; Derek N J Hart; Graham H Jackson; Gordon Cook; James Cavet; Stephen Mackinnon; Peter G Middleton; Anne M Dickinson
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.